Will Bausch + Lomb break free from debt-heavy Bausch Health? Sale rumours ignite market frenzy!
Bausch + Lomb saw its stock surge by 13% in Toronto, trading at 24.01 Canadian dollars (around $17.67), following a report by the Financial Times suggesting the eye care company is considering a sale. The possible sale is being considered as a way to separate from its heavily indebted parent company, Bausch Health Companies Inc. […]